PRISCILLA AMUMA: Open Payments
NPI 1285497222 · WESTFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$381 in 17 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $275 · 2025 $381
Food & beverage: $381
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $137 |
| Exact Sciences Corporation | 3 | $57 |
| Madrigal Pharmaceuticals | 1 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| Astellas Pharma US Inc | 1 | $26 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| Lilly USA, LLC | 1 | $24 |
| Amgen Inc. | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $19 |
Products named: VRAYLAR, REZDIFFRA, The Cologuard Plus Collection Kit, CAPLYTA, UBRELVY, Veozah, SPRAVATO, MOUNJARO.
Industry payments across MA — which companies pay providers there.
